Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy
Zhiwen Yao(The University of Texas MD Anderson Cancer Center), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Jörge E. Cortes(Augusta University Health), Maurilio Ponzoni(San Raffaele University of Rome), Eric D. Hsi(Mayo Clinic), Luis Fayad(The University of Texas MD Anderson Cancer Center), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(Duke University), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Y Li(Cleveland Clinic Lerner College of Medicine), Y Liu(Zhengzhou University), Wayne Tam(Cornell University), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Preetesh Jain(The University of Texas MD Anderson Cancer Center), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Jiajie Wang(The University of Texas MD Anderson Cancer Center), Lijuan Deng(Shandong University of Traditional Chinese Medicine), L. Jeffrey Medeiros(Delaware Division of Libraries), Yongping Song(Zhengzhou University), Jane N. Winter(Northwestern University)
Cited by 56
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k